Welcome to the Indiana Chapter Light The Night Walk page!

JOIN US AS WE CELEBRATE A DECADE OF DIFFERENCE. REGISTER FOR THE LIGHT THE NIGHT 10 YEAR ANNIVERSARY!

In the ten years since The Leukemia & Lymphoma Society’s (LLS) Light The Night® Walk began, the program has grown to include participants in more than 240 communities across the U.S. and Canada. Funds raised by these Walkers since program inception total nearly $120 million.  These funds have made a major impact on the lives of cancer patients and their families. They have helped fuel the growth of LLS-funded research and services that help patients live better, longer lives. 

Over the Past Decade:      

• Nearly half a million patients, family members and healthcare professionals have called the LLS Information Resource Center and received critical information about blood cancers, therapy options and issues surrounding treatment and survival.
  
• Nearly $40 million was disbursed to patients through the LLS Patient Assistance program, for transportation, lodging and other expenses, to help them get the treatment they needed to fight their cancer. 
  
• Over 100,000 patients and family members found comfort and hope through LLS  First Connection and Family Support Groups.
  
• LLS granted $425 million to more than 400 scientists searching for cures and improved treatments for patients.
  
• LLS funding contributed to the development of new drugs that are affecting patient survival and quality of life. Examples include:

              o Velcade® for the treatment of multiple myeloma and mantle cell
                  lymphoma
              o Dracogen® for myelodysplastic syndrome
              o Rituxan® for follicular lymphoma and diffuse large B-cell non-Hodgkin  
                  lymphoma
              o Gleevec® for chronic myelogenous leukemia

• LLS-funded researchers began working in novel research areas that hold 
   great promise for finding cures and better treatments including new, less toxic
   stem cell transplants, immunotherapies and other targeted therapies.
  
• Our Advocacy Network has successfully supported pro-patient legislation including:

              o Doubling NIH funding over a five-year period to advance blood cancer
                 research
              o Extending  Medicare coverage to include oral anti-cancer drugs such as  
                Gleevec®  and thalidomide.
              o Funding to reach underserved blood cancer patients at the Centers for
                 Disease Control and Prevention (CDC).

---------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Registration for the 2008 Walk season is open!

The Light The Night staff is excited to announce registration for the 2008 Walk season is open. We are busy planning and preparing to make this year's Light The Night Walks the best yet!

Be sure to register your team early, and encourage your team walkers to register as well. Click here for registration information and Walk site details.